Analysts Offer Insights on Healthcare Companies: Sumitomo Dainippon Pharma Co (OtherDNPUF ...
Analysts fell to the sidelines weighing in on Sumitomo Dainippon Pharma Co (DNPUF – Research Report) and Sanofi (SNYNF – Research Report) with ...
pharmaphorum5 年
Sumitomo, Roivant close $3 billion deal, forming Sumitovant
A new international biotech – Sumitovant Biopharma – has been created after Sumitomo Dainippon’s strategic alliance with Roivant Sciences came to fruition as 2019 drew to a close.
日本股市上涨；截至收盘日经225指数上涨0.61%
日经225指数 中表现最好的股票为Sumitomo Dainippon Pharma Co Ltd (TYO: 4506 )，上涨9.72%（69.00点），收盘报价为779.00。同时，住友电工 (TYO: 5802 ...
日本股市收低；截至收盘日经225指数下跌2.69%
日经225指数 中表现最好的股票为Sumitomo Dainippon Pharma Co Ltd (TYO: 4506 )，上涨16.39%（100.00点），收盘报价为710.00。同时，Konami Corp. (TYO: 9766 ...
Seeking Alpha6 天
DNPUF Sumitomo Pharma Co., Ltd.
Ltd. The company has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd.
来自MSN11 个月
日本股市上涨；截至收盘日经225指数上涨2.19%
Sumitomo Dainippon Pharma Co Ltd (TYO:4506)下跌2.51%（9.00点），收于349.00；CyberAgent Inc (TYO:4751)收盘时跌2.33%（24.50点），报价1,029.00。 东京证券交易所0只个股 ...
pharmaphorum2 年
Sumitomo ups ante and wins support for Myovant takeover
Sumitomo already held around 52% of the company ahead of the new offer – which values Myovant at around $2.9 billion – and is spending $1.7 billion to gain 100% ownership of its shares.